PI
IART icon

PEAK6 Investments’s Integra LifeSciences IART Stock Holding History

PEAK6 Investments’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-300
Closed -$19K – 5160
2020
Q4 		$19K Buy
+300
New +$16.1K ﹤0.01% 4338
2020
Q3 		– Sell
-2,200
Closed -$103K – 4598
2020
Q2 		$103K Sell
2,200
-2,800
-56% -$138K ﹤0.01% 3789
2020
Q1 		$223K Buy
+5,000
New +$262K ﹤0.01% 2759
2019
Q1 		– Sell
-4,200
Closed -$189K – 4178
2018
Q4 		$189K Sell
4,200
-17,900
-81% -$982K ﹤0.01% 3076
2018
Q3 		$1.46M Buy
+22,100
New +$1.37M 0.01% 1691

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PEAK6 Investments's IART Position: Q3 2024 in Review

PEAK6 Investments sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 3,653 shares — an estimated $106K sold.

PEAK6 Investments first reported a position in IART in Q3 2018 and held it in 11 quarters. The position peaked at $4.16M in Q3 2018. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • PEAK6 Investments reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 3,653 Integra LifeSciences shares in Q3 2024, an estimated $106K.
  • PEAK6 Investments first reported a position in Integra LifeSciences in Q3 2018 and held it in 11 quarters.
  • PEAK6 Investments's Integra LifeSciences position peaked at $4.16M in Q3 2018.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.